Author Correction: Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-01-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-024-44729-x |
| _version_ | 1827382134481879040 |
|---|---|
| author | Suad Hannawi Linda Saf Eldin Alaa Abuquta Ahmad Alamadi Sally A. Mahmoud Aala Hassan Shuping Xu Jian Li Dongfang Liu Adam Abdul Hakeem Baidoo Dima Ibrahim Mojtaba Alhaj Yuanxin Chen Qiang Zhou Liangzhi Xie |
| author_facet | Suad Hannawi Linda Saf Eldin Alaa Abuquta Ahmad Alamadi Sally A. Mahmoud Aala Hassan Shuping Xu Jian Li Dongfang Liu Adam Abdul Hakeem Baidoo Dima Ibrahim Mojtaba Alhaj Yuanxin Chen Qiang Zhou Liangzhi Xie |
| author_sort | Suad Hannawi |
| collection | DOAJ |
| first_indexed | 2024-03-08T14:15:09Z |
| format | Article |
| id | doaj.art-67fe0f183da34c06b539bb6974e54532 |
| institution | Directory Open Access Journal |
| issn | 2041-1723 |
| language | English |
| last_indexed | 2024-03-08T14:15:09Z |
| publishDate | 2024-01-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Nature Communications |
| spelling | doaj.art-67fe0f183da34c06b539bb6974e545322024-01-14T12:28:08ZengNature PortfolioNature Communications2041-17232024-01-011511110.1038/s41467-024-44729-xAuthor Correction: Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in menSuad Hannawi0Linda Saf Eldin1Alaa Abuquta2Ahmad Alamadi3Sally A. Mahmoud4Aala Hassan5Shuping Xu6Jian Li7Dongfang Liu8Adam Abdul Hakeem Baidoo9Dima Ibrahim10Mojtaba Alhaj11Yuanxin Chen12Qiang Zhou13Liangzhi Xie14Internal Medicine Department, Al Kuwait-Dubai (ALBaraha) HospitalGeneral Surgery Department, Al Kuwait-Dubai (ALBaraha) HospitalInternal Medicine Department, Al Kuwait-Dubai (ALBaraha) HospitalEar, Nose and Throat Department (ENT), Al Kuwait-Dubai (ALBaraha) HospitalBiogenix labs, G42 HealthcareInternal Medicine Department, Al Kuwait-Dubai (ALBaraha) HospitalBeijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd.Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd.Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd.Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd.Infectious Diseases Department, Burjeel Medical CityResearch Department, Burjeel Medical CityBeijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd.Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd.Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd.https://doi.org/10.1038/s41467-024-44729-x |
| spellingShingle | Suad Hannawi Linda Saf Eldin Alaa Abuquta Ahmad Alamadi Sally A. Mahmoud Aala Hassan Shuping Xu Jian Li Dongfang Liu Adam Abdul Hakeem Baidoo Dima Ibrahim Mojtaba Alhaj Yuanxin Chen Qiang Zhou Liangzhi Xie Author Correction: Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men Nature Communications |
| title | Author Correction: Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men |
| title_full | Author Correction: Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men |
| title_fullStr | Author Correction: Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men |
| title_full_unstemmed | Author Correction: Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men |
| title_short | Author Correction: Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men |
| title_sort | author correction safety and immunogenicity of a tetravalent and bivalent sars cov 2 protein booster vaccine in men |
| url | https://doi.org/10.1038/s41467-024-44729-x |
| work_keys_str_mv | AT suadhannawi authorcorrectionsafetyandimmunogenicityofatetravalentandbivalentsarscov2proteinboostervaccineinmen AT lindasafeldin authorcorrectionsafetyandimmunogenicityofatetravalentandbivalentsarscov2proteinboostervaccineinmen AT alaaabuquta authorcorrectionsafetyandimmunogenicityofatetravalentandbivalentsarscov2proteinboostervaccineinmen AT ahmadalamadi authorcorrectionsafetyandimmunogenicityofatetravalentandbivalentsarscov2proteinboostervaccineinmen AT sallyamahmoud authorcorrectionsafetyandimmunogenicityofatetravalentandbivalentsarscov2proteinboostervaccineinmen AT aalahassan authorcorrectionsafetyandimmunogenicityofatetravalentandbivalentsarscov2proteinboostervaccineinmen AT shupingxu authorcorrectionsafetyandimmunogenicityofatetravalentandbivalentsarscov2proteinboostervaccineinmen AT jianli authorcorrectionsafetyandimmunogenicityofatetravalentandbivalentsarscov2proteinboostervaccineinmen AT dongfangliu authorcorrectionsafetyandimmunogenicityofatetravalentandbivalentsarscov2proteinboostervaccineinmen AT adamabdulhakeembaidoo authorcorrectionsafetyandimmunogenicityofatetravalentandbivalentsarscov2proteinboostervaccineinmen AT dimaibrahim authorcorrectionsafetyandimmunogenicityofatetravalentandbivalentsarscov2proteinboostervaccineinmen AT mojtabaalhaj authorcorrectionsafetyandimmunogenicityofatetravalentandbivalentsarscov2proteinboostervaccineinmen AT yuanxinchen authorcorrectionsafetyandimmunogenicityofatetravalentandbivalentsarscov2proteinboostervaccineinmen AT qiangzhou authorcorrectionsafetyandimmunogenicityofatetravalentandbivalentsarscov2proteinboostervaccineinmen AT liangzhixie authorcorrectionsafetyandimmunogenicityofatetravalentandbivalentsarscov2proteinboostervaccineinmen |